Glioma targeting peptide in combination with the P53 C terminus inhibits glioma cell proliferation in vitro
D Wang, M Guo, J Yu, X Wang, Q Zhang, X Yang, J Li… - Cytotechnology, 2018 - Springer
Glioma is a prevalent malignant primary brain tumor in adults, the treatment for which
remains a challenge due to its high infiltration and recurrence. Hence, treatments that lead to
the suppression of glioma cell migration and invasion may be used in addition to surgery to …
remains a challenge due to its high infiltration and recurrence. Hence, treatments that lead to
the suppression of glioma cell migration and invasion may be used in addition to surgery to …
For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to ＞99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.
Quick Links:
Contact Information:
Eva He
eva@pepmic.com
Pepmic Co., Ltdeva@pepmic.com
www.pepmic.com
没有评论:
发表评论